These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11274326

  • 21. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
    Nanni S, Melandri G, Hanemaaijer R, Cervi V, Tomasi L, Altimari A, Van Lent N, Tricoci P, Bacchi L, Branzi A.
    Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
    [Abstract] [Full Text] [Related]

  • 22. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome.
    Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I.
    Lancet; 1996 Mar 09; 347(9002):702. PubMed ID: 8596427
    [No Abstract] [Full Text] [Related]

  • 23. Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis.
    Kobusiak-Prokopowicz M, Kaaz K, Marciniak D, Karolko B, Mysiak A.
    Kidney Blood Press Res; 2021 Mar 09; 46(6):749-757. PubMed ID: 34801997
    [Abstract] [Full Text] [Related]

  • 24. [Age-related dynamics of the contents of matrix metalloproteinases (MMP-1, -2, -3, -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -4) in blood plasma of residents of the European part of the Arctic zone of the Russian Federation.].
    Kim LB, Russkih GS, Putyatina AN, Tsypysheva OB.
    Adv Gerontol; 2018 Mar 09; 31(2):223-230. PubMed ID: 30080329
    [Abstract] [Full Text] [Related]

  • 25. Matrix metalloproteinases 2, 7, 9 and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors.
    Kushlinsky NE, Solovyov YN, Babkina IV, Gershtein ES, Bulicheva IV.
    Bull Exp Biol Med; 2010 Aug 09; 149(2):233-5. PubMed ID: 21113498
    [Abstract] [Full Text] [Related]

  • 26. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z.
    J Nephrol; 2007 Aug 09; 20(4):444-52. PubMed ID: 17879211
    [Abstract] [Full Text] [Related]

  • 27. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
    Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD, EURODIAB Prospective Complications Study Group.
    Cardiovasc Diabetol; 2015 Mar 10; 14():31. PubMed ID: 25848912
    [Abstract] [Full Text] [Related]

  • 28. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J, Patal S, Wexler D, Roth A, Sheps D, Keren G.
    Am Heart J; 2005 Sep 10; 150(3):484-7. PubMed ID: 16169329
    [Abstract] [Full Text] [Related]

  • 29. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia.
    Beaudeux JL, Giral P, Bruckert E, Bernard M, Foglietti MJ, Chapman MJ.
    Atherosclerosis; 2003 Jul 10; 169(1):139-46. PubMed ID: 12860260
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
    Derosa G, D'Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, Montagna L, Gravina A, Ferrari I, Galli S, Paniga S, Tinelli C, Cicero AF.
    Endothelium; 2006 Jul 10; 13(3):227-31. PubMed ID: 16840178
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.
    Dellalibera-Joviliano R, Jacob-Ferreira AL, Joviliano EE, Tanus-Santos JE, Evora PR.
    Vasc Med; 2012 Apr 10; 17(2):73-8. PubMed ID: 22402936
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.